Disagree
Home Deus Medical Deus Medical
TELMIMED 40
TELMIMED 40 - Deus Medical

TELMIMED 40 - Deus Medical

Brand:
Category:
Substance:
Dosage:
40 mg/tab
Package:
50 tablets
Price:
$22.00 - $22.00
See options
Product Overview

Telmisartan is mainly known for treating high blood pressure but new research suggests it can also slow down the growth of esophageal squamous cell carcinoma (ESCC). Helps stop cancer cells from dividing by causing S-phase arrest and lowering key proteins like cyclin A2 and CDK2. This means telmisartan could be a useful treatment for ESCC with benefits as a blood pressure medicine.

References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TELMIMED 40 by Deus Medical, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
What cellular mechanisms does telmisartan employ to inhibit cancer growth?
Lowers levels of cyclin A2 and CDK2, leading to S-phase cell-cycle arrest, which reduces cancer cell proliferation
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

Has telmisartan been studied in other types of cancer?
As per research was shown that antitumor effects in cancers such as endometrial, ovarian, lung, and colon cancers.
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.

What role do receptor tyrosine kinases (RTKs) play in telmisartan’s mechanism of action?
Telmisartan reduces the expression of ErbB3, a receptor tyrosine kinase, which contributes to its antitumor effects in ESCC cells.
References:

Matsui, T., Chiyo, T., Kobara, H., Fujihara, S., Fujita, K., Namima, D., Nakahara, M., Kobayashi, N., Nishiyama, N., Yachida, T., Morishita, A., Iwama, H., and Masaki, T. (2019) Telmisartan inhibits cell proliferation and tumor growth of esophageal squamous cell carcinoma by inducing S-phase arrest in vitro and in vivo', International Journal of Molecular Sciences.